ArticleAnnals of surgical oncology2026

Immune-Adjusted Nodal Risk Classification After Neoadjuvant Immunotherapy for Resectable Head and Neck Cutaneous Squamous Cell Carcinoma.

Yajing Du et al.PubMed ↗Publisher ↗

No numbers read from the abstract.